MediciNova Gross Profit from 2010 to 2025

MNOV Stock

USD 1.53 0.02 1.32%

MediciNova Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit will likely drop to about 855 K in 2025. Gross Profit is the profit MediciNova makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2004-03-31

Previous Quarter

-5.3 K

Current Value

-5.4 K

Quarterly Volatility

497.2 M

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.8 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.

Check out the analysis of MediciNova Correlation against competitors.

For more information on how to buy MediciNova Stock please use our How to Invest in MediciNova guide.

Latest MediciNova's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of MediciNova over the last few years. Gross profit is a required income statement account that reflects total revenue of MediciNova minus its cost of goods sold. It is profit before MediciNova operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. MediciNova's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 0

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

MediciNova Gross Profit Regression Statistics

	Arithmetic Mean	831,157
	Geometric Mean	0.00
	Coefficient Of Variation	207.28
	Mean Deviation	1,079,996
	Median	0.00
	Standard Deviation	1,722,862
	Sample Variance	3T
	Range	6.2M
	R-Value	(0.01)
	Mean Square Error	3.2T
	R-Squared	0.000052
	Significance	0.98
	Slope	(2,607)
	Total Sum of Squares	44.5T

MediciNova Gross Profit History

	2025	855 K
	2024	900 K
	2023	1000 K
	2022	-212.4 K
	2021	4 M
	2020	-21.3 K
	2019	-23.9 K

Other Fundumenentals of MediciNova

Gross Profit Margin

MediciNova Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Total Liab	Net Debt	Accounts Payable	Short Term Investments	Total Current Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Good Will	Short Term Debt	Intangible Assets	Net Tangible Assets	Capital Surpluse	Deferred Long Term Liab	Net Receivables	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	-0.74	-0.02	-0.86	0.18	0.24	0.99	0.87	-0.51	0.01	0.23	-0.27	-0.47	0.94	0.84	-0.78	-0.14	0.93	0.93	0.51
Total Stockholder Equity	1.0		-0.7	-0.06	-0.86	0.17	0.25	1.0	0.87	-0.46	0.02	0.19	-0.28	-0.42	0.95	0.85	-0.78	-0.08	0.93	0.93	0.5
Retained Earnings	-0.74	-0.7		-0.4	0.57	-0.33	-0.17	-0.64	-0.86	0.88	-0.05	-0.53	0.07	0.9	-0.64	-0.71	0.65	0.29	-0.55	-0.54	-0.55
Total Liab	-0.02	-0.06	-0.4		0.14	0.07	-0.08	-0.1	0.07	-0.72	0.3	-0.04	0.64	-0.72	-0.22	-0.23	0.3	0.25	-0.24	-0.23	-0.31
Net Debt	-0.86	-0.86	0.57	0.14		-0.32	0.13	-0.86	-0.74	0.31	0.09	-0.3	0.32	0.29	-0.87	-0.79	0.73	0.22	-0.82	-0.82	-0.55
Accounts Payable	0.18	0.17	-0.33	0.07	-0.32		-0.13	0.16	0.37	-0.22	-0.17	0.4	-0.16	-0.21	0.26	0.39	-0.47	-0.26	0.05	0.04	0.36
Short Term Investments	0.24	0.25	-0.17	-0.08	0.13	-0.13		0.26	0.24	-0.06	-0.27	-0.08	-0.35	-0.03	0.22	0.26	-0.33	0.09	0.24	0.23	0.23
Total Current Assets	0.99	1.0	-0.64	-0.1	-0.86	0.16	0.26		0.84	-0.4	0.01	0.15	-0.29	-0.35	0.96	0.83	-0.76	-0.05	0.93	0.93	0.47
Common Stock	0.87	0.87	-0.86	0.07	-0.74	0.37	0.24	0.84		-0.61	0.04	0.46	-0.27	-0.61	0.89	0.93	-0.79	-0.15	0.68	0.67	0.65
Property Plant Equipment	-0.51	-0.46	0.88	-0.72	0.31	-0.22	-0.06	-0.4	-0.61		-0.19	-0.4	-0.25	0.96	-0.34	-0.38	0.32	0.16	-0.29	-0.29	-0.26
Current Deferred Revenue	0.01	0.02	-0.05	0.3	0.09	-0.17	-0.27	0.01	0.04	-0.19		-0.28	0.77	-0.24	-0.11	-0.22	0.44	0.36	-0.17	-0.14	-0.58
Good Will	0.23	0.19	-0.53	-0.04	-0.3	0.4	-0.08	0.15	0.46	-0.4	-0.28		-0.36	-0.39	0.35	0.56	-0.52	-0.82	0.19	0.16	0.79
Short Term Debt	-0.27	-0.28	0.07	0.64	0.32	-0.16	-0.35	-0.29	-0.27	-0.25	0.77	-0.36		-0.31	-0.45	-0.55	0.72	0.46	-0.41	-0.38	-0.78
Intangible Assets	-0.47	-0.42	0.9	-0.72	0.29	-0.21	-0.03	-0.35	-0.61	0.96	-0.24	-0.39	-0.31		-0.29	-0.35	0.27	0.11	-0.24	-0.24	-0.22
Net Tangible Assets	0.94	0.95	-0.64	-0.22	-0.87	0.26	0.22	0.96	0.89	-0.34	-0.11	0.35	-0.45	-0.29		0.95	-0.84	-0.16	0.88	0.87	0.66
Capital Surpluse	0.84	0.85	-0.71	-0.23	-0.79	0.39	0.26	0.83	0.93	-0.38	-0.22	0.56	-0.55	-0.35	0.95		-0.91	-0.33	0.75	0.74	0.83
Deferred Long Term Liab	-0.78	-0.78	0.65	0.3	0.73	-0.47	-0.33	-0.76	-0.79	0.32	0.44	-0.52	0.72	0.27	-0.84	-0.91		0.47	-0.78	-0.76	-0.86
Net Receivables	-0.14	-0.08	0.29	0.25	0.22	-0.26	0.09	-0.05	-0.15	0.16	0.36	-0.82	0.46	0.11	-0.16	-0.33	0.47		-0.24	-0.22	-0.65
Net Invested Capital	0.93	0.93	-0.55	-0.24	-0.82	0.05	0.24	0.93	0.68	-0.29	-0.17	0.19	-0.41	-0.24	0.88	0.75	-0.78	-0.24		1.0	0.52
Net Working Capital	0.93	0.93	-0.54	-0.23	-0.82	0.04	0.23	0.93	0.67	-0.29	-0.14	0.16	-0.38	-0.24	0.87	0.74	-0.76	-0.22	1.0		0.49
Capital Stock	0.51	0.5	-0.55	-0.31	-0.55	0.36	0.23	0.47	0.65	-0.26	-0.58	0.79	-0.78	-0.22	0.66	0.83	-0.86	-0.65	0.52	0.49

Click cells to compare fundamentals

About MediciNova Financial Statements

MediciNova investors use historical fundamental indicators, such as MediciNova's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MediciNova. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	900 K	855 K
Gross Profit Margin	0.40	0.23

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MediciNova Stock Analysis

When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC